Hold with explicit trigger architecture pending Q3 earnings; reject staged adds per 9/21 binding
Hold with explicit trigger architecture is the rating that honors all three analyst perspectives while applying the binding reflection hierarchy: weight structural supports (capital return yield, NII runway, franchise quality) more heavily per 9/24, reject staged adds per 9/21, and activate discipline per 9/25 and 9/10. Patience is the correct risk-adjusted posture until Q3 resolves the NIM-peak question and the technical picture clarifies. Price target remains $100.0.
| Position | Action |
|---|---|
| Current position | Neutral weight with NO incremental capital deployment |
| Upgrade to Overweight triggers met | Scale to full weight on Q3 beat-and-raise confirmation |
| Downgrade to Underweight triggers met | Reduce exposure; trim into strength per 9/24 binding |
SCHW's technical breakdown is a gift-wrapped entry: the 200 SMA holds support, RSI is oversold at 29.84, and declining volume confirms accumulation, while fundamentally the company is accelerating (20.9% revenue growth, 42.6% EPS growth, 19% NII growth) at a deeply discounted 12.55x forward P/E with a 6% buyback yield and macro tailwinds from sustained elevated rates.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $101.92 | bearish |
| 50 SMA | $106.47 | bearish |
| 200 SMA | $97.81 | neutral |
| MACD Line | −2.19 | bearish |
| MACD Histogram | −1.07 | bearish |
| RSI(14) | 29.84 | neutral |
| Bollinger Upper Band | $113.13 | bearish |
| Bollinger Mid Band (20 SMA) | $105.38 | bearish |
| Bollinger Lower Band | $97.64 | bullish |
| ATR(14) | $2.36 | neutral |
Support: 97.75 · 97.81 · 96 · 95 | Resistance: 100 · 101.92 · 104 · 105
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close <$97.00 on volume >8M shares (200 SMA regime change) OR 10Y >5.10% sustained with AOCI hole widening beyond $13B AND Polymarket no-cut dropping below 80%
Then: Reduce conviction; base case cascade target $92-$94
Accelerating fundamentals at a deep discount: 20%+ revenue growth, 40%+ EPS growth, expanding margins, and NIM expansion are being ignored by a market pricing SCHW at a significant P/E discount to the S&P 500
EV: +84% (bull case $180) · concedes: Bear correctly identifies eight bearish technical indicators (below 10 EMA, 50 SMA, lower Bollinger Band, negative MACD, RSI oversold); The AI disruption narrative from Meta Muse is a real competitive concern worth monitoring; Short-term price action remains under pressure from macro headwinds; The 200 SMA support at $97.81 could eventually break on sustained negative momentum
SCHW is buying a falling knife with both hands — the stock has fallen from $114 to $98 despite $11B+ in buybacks, technicals show accelerating downside momentum (MACD histogram widening from −0.58 to −1.07), the 42.6% EPS growth is partially mechanical from share reduction rather than operational strength, NIM expansion is decelerating as HTM roll benefits diminish, and the bull's upside scenarios are unstress-tested while realistic downside extends to $85–$90.
EV: ~$112.95 probability-weighted price (vs. bull's claimed ~$125 consensus target and $180 bull case) · concedes: SCHW's reported numbers are strong: 20.9% revenue growth, 42.6% EPS growth, 19% NII growth; The HTM roll and deposit cost improvements are 'live, not theoretical' tailwinds — just with diminishing returns; The AOCI improvement is real — $12.59B → $10.58B — it's just glacially slow; Q3 NII acceleration is a reasonable expectation for the print; Claude integration is real progress on AI — the bear just doesn't think it's a durable moat
→ vs conservative: MACD histogram widening is misread as bearish continuation when it's actually climax move signature at oversold 200 SMA support—divergence requires price action AFTER the curl, not before
→ vs conservative: 200 SMA margin argument misses structural support track record since mid-2024; capitulation volume already exhausted marginal sellers
→ vs neutral: Q3 earnings framing as binary justifies patient stance but asymmetric setup isn't priced fairly—the Polymarket odds already price the outcome
→ vs neutral: Conservative 50% tranche scaling gives up entire risk premium for being early; at $98 with 12.5x earnings, 20% ROE, and 6% buyback yield, full position is warranted
SCHW is in a sharp downtrend with price testing the 200-day SMA at $97.81 as the last major technical support, sitting just $0.49 above it. All three trend averages (10 EMA at $101.92, 50 SMA at $106.47, and 200 SMA at $97.81) are confirmed bearish, with MACD histogram still widening negative at −1.07 and RSI collapsed to 29.84 (oversold). The convergence of RSI oversold, Bollinger lower band touch at $97.64, and declining volume on new lows (6–8M vs 16.9M capitulation day) suggests the stock is technically stretched, warranting a HOLD stance until either $97.75 breaks bearish or price reclaims $101.92 on volume above 8M for a bullish reversal.
Market Cap
$169.99B
P/E (TTM)
17.91
Forward P/E
12.55
PEG Ratio
0.84
P/B
3.87
EPS (TTM)
$5.49
Forward EPS
$7.83
Dividend Yield
1.29%
Beta
0.753
52-Week High
$114.53
52-Week Low
$83.96
50-Day MA
$106.65
200-Day MA
$98.28
Revenue (TTM)
$26.03B
Gross Profit
$25.37B
Net Income (TTM)
$9.72B
Profit Margin
38.79%
Operating Margin
52.28%
ROE
20.27%
ROA
2.07%
Book Value/Share
$25.42
Q2 2025 Revenue
$5.851B
Q2 2025 Net Interest Income
$2.822B
Q2 2025 Interest Expense
$956M
Q2 2025 Net Income
$2.126B
Q2 2025 Diluted EPS
$1.08
Q3 2025 Revenue
$6.135B
Q3 2025 Net Interest Income
$3.050B
Q3 2025 Interest Expense
$906M
Q3 2025 Net Income
$2.358B
Q3 2025 Diluted EPS
$1.26
Q4 2025 Revenue
$6.336B
Q4 2025 Net Interest Income
$3.172B
Q4 2025 Interest Expense
$832M
Q4 2025 Net Income
$2.459B
Q4 2025 Diluted EPS
$1.33
Q1 2026 Revenue
$6.482B
Q1 2026 Net Interest Income
$3.144B
Q1 2026 Interest Expense
$818M
Q1 2026 Net Income
$2.479B
Q1 2026 Diluted EPS
$1.37
Q2 2026 Revenue
$7.072B
Q2 2026 Net Interest Income
$3.357B
Q2 2026 Interest Expense
$789M
Q2 2026 Net Income
$2.800B
Q2 2026 Diluted EPS
$1.54
Revenue Growth YoY Q2 2026
+20.9%
Net Interest Income Growth YoY Q2 2026
+19.0%
Net Income Growth YoY Q2 2026
+31.7%
Diluted EPS Growth YoY Q2 2026
+42.6%
Interest Expense Change YoY
−17.5%
Q2 2026 Total Assets
$517.27B
Q1 2026 Total Assets
$493.32B
Q4 2025 Total Assets
$490.99B
Q3 2025 Total Assets
$465.26B
Q2 2025 Total Assets
$458.94B
Q2 2025 to Q2 2026 Total Assets Growth
+$58B
Q2 2026 Cash & Equivalents
$40.58B
Q2 2026 Cash + Fed Funds Sold
$73.59B
Q2 2026 Held-to-Maturity Securities
$126.64B
Q2 2026 Investments & Advances
$188.34B
Q2 2026 Net Loans
$66.99B
Q2 2025 Net Loans
$50.41B
Q2 2026 Receivables
$144.85B
Q2 2025 Receivables
$87.09B
Q2 2026 Total Equity
$50.15B
Q2 2025 Total Equity
$49.45B
Q2 2026 Common Stock Equity
$43.93B
Q2 2025 Common Stock Equity
$42.69B
Q2 2026 Preferred Stock
$6.21B
Q2 2025 Preferred Stock
$6.76B
Q2 2026 Long-Term Debt
$22.88B
Q2 2025 Long-Term Debt
$20.16B
Q2 2026 Total Debt
$37.35B
Q2 2025 Total Debt
$37.67B
Q4 2025 Total Debt
$30.95B
Q3 2025 Total Debt
$27.58B
Net Debt Q2 2025
$5.44B
Q2 2026 Tangible Book Value
$24.36B
Q2 2025 Tangible Book Value
$23.25B
Q2 2026 AOCI Losses
−$10.58B
Q2 2025 AOCI Losses
−$12.59B
Q2 2026 Operating Cash Flow
$4.30B
Q1 2026 Operating Cash Flow
$7.34B
Q4 2025 Operating Cash Flow
−$0.76B
Q3 2025 Operating Cash Flow
$0.54B
Q2 2025 Operating Cash Flow
$3.18B
Q2 2026 Free Cash Flow
$4.12B
Q1 2026 Free Cash Flow
$7.20B
Q4 2025 Free Cash Flow
−$0.92B
Q3 2025 Free Cash Flow
$0.39B
Q2 2025 Free Cash Flow
$3.05B
H1 2026 Free Cash Flow
$11.3B
Q2 2026 CapEx
−$0.185B
Q2 2025 CapEx
−$0.128B
Q2 2026 Share Buybacks
−$3.054B
Q1 2026 Share Buybacks
−$2.378B
Q4 2025 Share Buybacks
−$2.765B
Q3 2025 Share Buybacks
−$2.748B
Q2 2025 Share Buybacks
−$2.791B
H1 2026 Share Buybacks
$5.4B
Q2 2026 Dividends Paid
−$0.643B
Q2 2025 Dividends Paid
−$0.608B
Q2 2026 End Cash Position
$69.20B
Q2 2025 End Cash Position
$55.57B
Q2 2026 Net Debt Issuance
+$3.63B
Q1 2026 Net Debt Issuance
+$2.09B
Q4 2025 Net Debt Issuance
+$3.34B
Q3 2025 Net Debt Issuance
−$10.10B
Q2 2025 Net Debt Issuance
−$2.23B
H1 2026 Shareholder Returns
$11B+
Annualized Buyback Yield
~6%
Debt/Equity
151.1
AOCI Improvement YoY
~$2B
Strengths
Concerns
The fundamental setup is decisively positive with earnings inflection, NIM tailwind, attractive forward multiple (12.55x), active capital returns (~$6% annualized buyback yield), and improving balance sheet. BUY supported by fundamentals with risk management around rate-cycle shifts.